» Articles » PMID: 3508549

Multiple-dose Pharmacokinetics of Clozapine in Patients

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1987 Oct 1
PMID 3508549
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

After a 2-day buildup, patients were dosed continuously with clozapine solution at three ascending dose levels (37.5, 75, and 150 mg bid for 7 days at each dose level). Following the morning administration on the twenty-third day of dosing a drug holiday was instituted which lasted for a minimum of 48 hr. Serial plasma samples were obtained during each of the periods and during the drug holiday for the calculation of the steady-state parameters AUCSS, CSSmax, and CSSmin at each dose level as well as for the assessment of the terminal elimination rate. Mean parameter values for AUCSS, CSSmax, and CSSmin showed a linearly increasing response with the dose, well described by a straight line passing through the origin. The terminal elimination appeared to follow linear kinetics and had a mean half-life of 15.8 hr (range, 5.8-33 hr).

Citing Articles

Alternative Routes of Administration of Clozapine.

Gee S, Taylor D CNS Drugs. 2022; 36(2):105-111.

PMID: 35113345 DOI: 10.1007/s40263-022-00900-w.


Intramuscular clozapine in the acute medical hospital: Experiences from a liaison psychiatry team.

Gee S, McMullen I, Wyke C, Yeoh S, Taylor D SAGE Open Med Case Rep. 2021; 9:2050313X211004796.

PMID: 34094561 PMC: 8141995. DOI: 10.1177/2050313X211004796.


Population Pharmacokinetics of Clozapine: A Systematic Review.

Albitar O, Harun S, Zainal H, Ibrahim B, Sheikh Ghadzi S Biomed Res Int. 2020; 2020:9872936.

PMID: 31998804 PMC: 6970501. DOI: 10.1155/2020/9872936.


Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.

Mauri M, Paletta S, Di Pace C, Reggiori A, Cirnigliaro G, Valli I Clin Pharmacokinet. 2018; 57(12):1493-1528.

PMID: 29915922 DOI: 10.1007/s40262-018-0664-3.


In Vivo Tissue Pharmacokinetics of Carbon-11-Labeled Clozapine in Healthy Volunteers: A Positron Emission Tomography Study.

Park H, Kim E, Moon B, Lim N, Lee B, Kim S CPT Pharmacometrics Syst Pharmacol. 2015; 4(5):305-11.

PMID: 26225256 PMC: 4452936. DOI: 10.1002/psp4.38.


References
1.
Gauch R, Michaelis W . The metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e) (1,4)diazepine (clozapine) in mice, dogs and human subjects. Farmaco Prat. 1971; 26(11):667-81. View

2.
Stock B, Spiteller G, Heipertz R . [Exchange of aromatically bound halogen for OH- and SCH3-groups in metabolising clozapine in the human organism (author's transl)]. Arzneimittelforschung. 1977; 27(5):982-90. View

3.
Heipertz R, Pilz H, Beckers W . Serum concentrations of clozapine determined by nitrogen selective gas chromatography. Arch Toxicol. 1977; 37(4):313-8. DOI: 10.1007/BF00330823. View